Sichuan Yangtian Bio-Pharmaceutical

Sichuan Yangtian Bio-Pharmaceutical Co., Ltd. is a prominent Chinese pharmaceutical company based in Chengdu, specializing in the development, manufacture, and marketing of biochemical and botanical medicines. Founded in 2001, the company has established a significant presence in the domestic market through its Yangtian brand, focusing primarily on cardiovascular and cerebrovascular health. Its core product portfolio includes Alprostadil for injection and Ginkgo Biloba extracts, which are widely utilized for treating peripheral vascular diseases and cognitive impairments. The company operates state-of-the-art, GMP-certified production facilities and maintains a robust quality control system to ensure the efficacy of its biochemical products. Sichuan Yangtian emphasizes technological innovation and has expanded its research efforts into anti-tumor and hepatoprotective therapies. As a key player in the Sichuan biopharmaceutical cluster, the company continues to pursue growth through both independent R&D and strategic industrial upgrades.